Dompé Farmaceutici S.p.a

This study followed 24 patients with a rare eye condition called neurotrophic keratitis to see if the benefits of a prescription eye drop (OXERVATE) lasted long-term. Patients had previously received up to 8 weeks of treatment and were then monitored for 30 months to check if the…

This study tested the safety and effectiveness of OXERVATE eye drops for treating an early stage of neurotrophic keratitis, a condition where the cornea doesn't heal properly due to nerve damage. Thirty-seven adult patients used the drops for 8 weeks and were followed for an addi…

This study tested if adding an experimental drug called reparixin to standard hospital care helps adults with severe Acute Respiratory Distress Syndrome (ARDS). ARDS is a life-threatening condition where the lungs fill with fluid, often requiring a ventilator to breathe. The tria…

This study tested a new eye drop containing a protein called nerve growth factor (rhNGF) to see if it could safely improve symptoms of dry eye disease. Over 300 adults with moderate-to-severe dry eye used either one of two strengths of the new drop or a placebo drop three times a…

This study tested whether adding a new eye drop called cenegermin (Oxervate) to standard cyclosporine treatment could better help people with severe dry eye from Sjogren's syndrome. For 4 weeks, 85 participants used either the new drop or a placebo (vehicle) three times a day, wh…